Introduction to the Special Issue on Clostridioides difficile
Funding
Conflicts of Interest
References
- Magill, S.S.; O’Leary, E.; Janelle, S.J.; Thompson, D.L.; Dumyati, G.; Nadle, J.; Wilson, L.E.; Kainer, M.A.; Lynfield, R.; Greissman, S.; et al. Changes in prevalence of health care-associated infections in U.S. Hospitals. N. Engl. J. Med. 2018, 379, 1732–1744. [Google Scholar] [CrossRef] [PubMed]
- Suetens, C.; Latour, K.; Kärki, T.; Ricchizzi, E.; Kinross, P.; Moro, M.L.; Jans, B.; Hopkins, S.; Hansen, S.; Lyytikäinen, O.; et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: Results from two European point prevalence surveys, 2016 to 2017. Eurosurveillance 2018, 23, 1800516. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McDonald, L.C.; Gerding, D.N.; Johnson, S.; Bakken, J.S.; Carroll, K.C.; Coffin, S.E.; Dubberke, E.R.; Garey, K.W.; Gould, C.V.; Kelly, C.; et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin. Infect. Dis. 2018, 66, e1–e48. [Google Scholar] [CrossRef] [PubMed]
- Granata, G.; Petrosillo, N.; Adamoli, L.; Bartoletti, M.; Bartoloni, A.; Basile, G.; Bassetti, M.; Bonfanti, P.; Borromeo, R.; Ceccarelli, G.; et al. Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections. J. Clin. Med. 2021, 10, 1127. [Google Scholar] [CrossRef] [PubMed]
- Kwon, J.H.; Olsen, M.A.; Dubberke, E.R. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect. Dis. Clin. N. Am. 2015, 29, 123–134. [Google Scholar] [CrossRef] [PubMed]
- Cataldo, M.A.; Granata, G.; Petrosillo, N. Clostridium difficile infection: New approaches to prevention, non-antimicrobial treatment, and stewardship. Expert Rev. Anti Infect. Ther. 2017, 15, 1027–1040. [Google Scholar] [CrossRef] [PubMed]
- Cataldo, M.A.; Granata, G.; D’Arezzo, S.; Tonziello, G.; Vulcano, A.; De Giuli, C.; Meledandri, M.; Di Caro, A.; Petrosillo, N. Hospitalized patients with diarrhea: Rate of Clostridioides difficile infection underdiagnosis and drivers of clinical suspicion. Anaerobe 2021, 70, 102380. [Google Scholar] [CrossRef] [PubMed]
- Granata, G.; Bartoloni, A.; Codeluppi, M.; Contadini, I.; Cristini, F.; Fantoni, M.; Ferraresi, A.; Fornabaio, C.; Grasselli, S.; Lagi, F.; et al. The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid). J. Clin. Med. 2020, 9, 3855. [Google Scholar] [CrossRef] [PubMed]
- Petrosillo, N.; Granata, G.; Cataldo, M.A. Novel Antimicrobials for the Treatment of Clostridium difficile Infection. Front. Med. 2018, 5, 96. [Google Scholar] [CrossRef] [PubMed]
- Wongkuna, S.; Janvilisri, T.; Phanchana, M.; Harnvoravongchai, P.; Aroonnual, A.; Aimjongjun, S.; Malaisri, N.; Chankhamhaengdecha, S. Temporal Variations in Patterns of Clostridioides difficile Strain Diversity and Antibiotic Resistance in Thailand. Antibiotics 2021, 10, 714. [Google Scholar] [CrossRef] [PubMed]
- Novakova, E.; Stofkova, Z.; Sadlonova, V.; Hleba, L. Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample. Antibiotics 2021, 10, 1035. [Google Scholar] [CrossRef]
- Granata, G.; Mariotti, D.; Ascenzi, P.; Petrosillo, N.; di Masi, A. High Serum Levels of Toxin A Correlate with Disease Severity in Patients with Clostridioides difficile Infection. Antibiotics 2021, 10, 1093. [Google Scholar] [CrossRef]
- Czepiel, J.; Krutova, M.; Mizrahi, A.; Khanafer, N.; Enoch, D.A.; Patyi, M.; Deptuła, A.; Agodi, A.; Nuvials, X.; Pituch, H.; et al. Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study. Antibiotics 2021, 10, 299. [Google Scholar] [CrossRef]
- Voicu, M.N.; Popescu, F.; Florescu, D.N.; Rogoveanu, I.; Turcu-Stiolica, A.; Gheonea, D.I.; Iovanescu, V.F.; Iordache, S.; Cazacu, S.M.; Ungureanu, B.S. Clostridioides difficile Infection among Cirrhotic Patients with Variceal Bleeding. Antibiotics 2021, 10, 731. [Google Scholar] [CrossRef]
- Šamadan, L.; Jeličić, M.; Vince, A.; Papić, N. Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection. Antibiotics 2021, 10, 780. [Google Scholar] [CrossRef] [PubMed]
- Ojha, S.C.; Phanchana, M.; Harnvoravongchai, P.; Chankhamhaengdecha, S.; Singhakaew, S.; Ounjai, P.; Janvilisri, T. Teicoplanin Suppresses Vegetative Clostridioides difficile and Spore Outgrowth. Antibiotics 2021, 10, 984. [Google Scholar] [CrossRef] [PubMed]
- Heidebrecht, H.-J.; Lagkouvardos, I.; Reitmeier, S.; Hengst, C.; Kulozik, U.; Pfaffl, M.W. Alteration of Intestinal Microbiome of Clostridioides difficile-Infected Hamsters during the Treatment with Specific Cow Antibodies. Antibiotics 2021, 10, 724. [Google Scholar] [CrossRef] [PubMed]
- Pellissery, A.J.; Vinayamohan, P.G.; Kuttappan, D.A.; Mishra, N.; Fragomeni, B.d.O.; Maas, K.; Mooyottu, S.; Venkitanarayanan, K. Protective Effect of Baicalin against Clostridioides difficile Infection in Mice. Antibiotics 2021, 10, 926. [Google Scholar] [CrossRef] [PubMed]
- Mahadari, M.K.; Jennepalli, S.; Tague, A.J.; Putsathit, P.; Hutton, M.L.; Hammer, K.A.; Knight, D.R.; Riley, T.V.; Lyras, D.; Keller, P.A.; et al. Cationic Peptidomimetic Amphiphiles Having a N-Aryl- or N-Naphthyl-1,2,3-Triazole Core Structure Targeting Clostridioides (Clostridium) difficile: Synthesis, Antibacterial Evaluation, and an In Vivo C. difficile Infection Model. Antibiotics 2021, 10, 913. [Google Scholar] [CrossRef] [PubMed]
- Wang, P.-W.; Lee, W.-T.; Wu, Y.-N.; Shieh, D.-B. Opportunities for Nanomedicine in Clostridioides difficile Infection. Antibiotics 2021, 10, 948. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Granata, G.; Donno, D.R. Introduction to the Special Issue on Clostridioides difficile. Antibiotics 2021, 10, 1233. https://doi.org/10.3390/antibiotics10101233
Granata G, Donno DR. Introduction to the Special Issue on Clostridioides difficile. Antibiotics. 2021; 10(10):1233. https://doi.org/10.3390/antibiotics10101233
Chicago/Turabian StyleGranata, Guido, and Davide Roberto Donno. 2021. "Introduction to the Special Issue on Clostridioides difficile" Antibiotics 10, no. 10: 1233. https://doi.org/10.3390/antibiotics10101233